4.7 Article

CT-based delineation of organs at risk in the head and neck region: DAHANCA, EORTC, GORTEC, HKNPCSG, NCIC CTG, NCRI, NRG Oncology and TROG consensus guidelines

Journal

RADIOTHERAPY AND ONCOLOGY
Volume 117, Issue 1, Pages 83-90

Publisher

ELSEVIER IRELAND LTD
DOI: 10.1016/j.radonc.2015.07.041

Keywords

Head and neck; Organs at risk; Interobserver variability; Consensus delineation guidelines

Ask authors/readers for more resources

Purpose: The objective of this project was to define consensus guidelines for delineating organs at risk (OARS) for head and neck radiotherapy for routine daily, practice and for research purposes. Methods: Consensus guidelines were formulated based on in-depth discussions of a panel of European, North American, Asian and Australian radiation oncologists. Results: Twenty-five OARS in the head and neck region were defined with a concise description of their main anatomic boundaries. The Supplemental material provides an atlas of the consensus guidelines, projected on 1 mm axial slices. The atlas can also be obtained in DICOM-RT format on request. Conclusion: Consensus guidelines for head and neck OAR delineation were defined, aiming to decrease interobserver variability among clinicians and radiotherapy centers. (C) 2015 The Authors. Published by Elsevier Ireland Ltd.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.7
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

Article Oncology

Head and neck cancer predictive risk estimator to determine control and therapeutic outcomes of radiotherapy (HNC-PREDICTOR): development, international multi-institutional validation, and web implementation of clinic-ready model-based risk stratification for head and neck cancer

Lisanne V. van Dijk, Abdallah S. R. Mohamed, Sara Ahmed, Nafiul Nipu, G. Elisabeta Marai, Kareem Wahid, Nanna M. Sijtsema, Brandon Gunn, Adam S. Garden, Amy Moreno, Andrew J. Hope, Johannes A. Langendijk, Clifton D. Fuller

Summary: By utilizing "big-data," a personalized radiotherapy prediction model was developed to accurately stratify patients with head and neck cancer into high, intermediate, and low mortality risk groups, providing guidance for personalized radiotherapy.

EUROPEAN JOURNAL OF CANCER (2023)

Article Oncology

Cardiac Function Modifies the Impact of Heart Base Dose on Survival: A Voxel-Wise Analysis of Patients With Lung Cancer From the PET-Plan Trial

Matthew Craddock, Ursula Nestle, Jochem Koenig, Tanja Schimek-Jasch, Stephanie Kremp, Stefan Lenz, Kathryn Banfill, Angela Davey, Gareth Price, Ahmed Salem, Corinne Faivre-Finn, Marcel van Herk, Alan McWilliam

Summary: This study analyzes the overall survival of patients with inoperable stage II or III NSCLC treated with radiotherapy, and for the first time includes left ventricular ejection fraction as a metric of cardiac function. The results indicate that there is a region within the base of the heart that is significantly associated with worse overall survival, and an interaction between baseline cardiac health and heart base dose was identified.

JOURNAL OF THORACIC ONCOLOGY (2023)

Article Oncology

Automated Robust Planning for IMPT in Oropharyngeal Cancer Patients Using Machine Learning

Ilse G. van Bruggen, Merle Huiskes, Suzanne P. M. de Vette, Mats Holmstrom, Johannes A. Langendijk, Stefan Both, Roel G. J. Kierkels, Erik W. Korevaar

Summary: The aim of this study was to evaluate an automated treatment planning method for robustly optimized intensity modulated proton therapy (IMPT) plans for oropharyngeal carcinoma patients and compare them with manually optimized plans. The results showed that the automated planning method can generate robustly optimized IMPT plans with comparable quality to clinical plans.

INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS (2023)

Article Radiology, Nuclear Medicine & Medical Imaging

Technical note: A knowledge graph approach to registering tumour specific data of patient-candidates for proton therapy in the Netherlands

Petros Kalendralis, Matthijs Sloep, Ananya Choudhury, Lerau Seyben, Jasper Snel, Nibin Moni George, Joeri Veugen, Martijn Veening, Johannes A. Langendijk, Andre Dekker, Johan van Soest, Rianne Fijten

Summary: This study provides an overview of the tumour group data lists in the Dutch national proton therapy registry, and presents a knowledge graph approach using ontologies and semantic web technologies to describe head and neck tumour variables. The goal is to offer a flexible and interoperable data model for data exchange in the radiotherapy community, highlighting variables needed for the model-based approach.

MEDICAL PHYSICS (2023)

Article Radiology, Nuclear Medicine & Medical Imaging

Clinical outcome after pencil beam scanning proton therapy and dysphagia/xerostomia NTCP calculations of proton and photon radiotherapy delivered to patients with cancer of the major salivary glands

Marc Andrea Walser, Nicolas Bachmann, Jonas Kluckert, A. Kothe, Carson Tully, Dominic Leiser, Antony John Lomax, Nicola Bizzocchi, Johannes Albertus Langendijk, Damien C. Weber

Summary: The objective of this study is to report the outcomes, toxicities, and NTCP calculation for PBSPT in SGT patients. The study reviewed 26 SGT patients treated with PBSPT and estimated overall survival, local control, locoregional control, and distant control. The results showed good oncological outcomes and low toxicity rates, and NTCP calculation indicated reduced risk for certain complications.

BRITISH JOURNAL OF RADIOLOGY (2023)

Article Otorhinolaryngology

The relation between hypoxia and proliferation biomarkers with radiosensitivity in locally advanced laryngeal cancer

Karlijn van den Bovenkamp, Bert van der Vegt, Gyorgy B. Halmos, Lorian Slagter-Menkema, Johannes A. Langendijk, Boukje A. C. van Dijk, Ed Schuuring, Bernard F. A. M. van der Laan

Summary: This study examined the predictive value of various tumor markers in patients with advanced-stage laryngeal squamous cell carcinoma, and found that overexpression of HIF-1α was associated with locoregional recurrence.

EUROPEAN ARCHIVES OF OTO-RHINO-LARYNGOLOGY (2023)

Article Oncology

Prediction of Radiation-Induced Parotid Gland-Related Xerostomia in Patients With Head and Neck Cancer: Regeneration-Weighted Dose

Maria I. van Rijn-Dekker, Peter van Luijk, Ewoud Schuit, Arjen van der van der Schaaf, Johannes A. Langendijk, Role J. H. M. Steenbakkers

Summary: The purpose of this study was to find a dose metric to better assess the risk of xerostomia in patients with head and neck cancer undergoing radiation therapy. The distribution of stem cells in the parotid gland was found to be associated with the extent of gland damage, and a regeneration-weighted dose that takes into account this distribution difference was shown to more accurately assess the risk. Additionally, pretreatment xerostomia and oral cavity dose were also identified as predictive factors for xerostomia.

INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS (2023)

Editorial Material Oncology

Think big-think BiGART. The 21st Acta Oncologica Symposium-BiGART 2023

Jesper Grau Eriksen, Birgitte Vrou Offersen, Morten Hoyer, Cai Grau, Jens Overgaard

ACTA ONCOLOGICA (2023)

Article Radiology, Nuclear Medicine & Medical Imaging

Partitioning of discrete proton arcs into interlaced subplans can bring proton arc advances to existing proton facilities

Erik Engwall, Otte Marthin, Viktor Wase, Johan Sundstrom, Victor Mikhalev, Bas A. de Jong, Johannes A. Langendijk, Henrik Melbeus, Bjorn Andersson, Erik W. Korevaar, Stefan Both, Rasmus Bokrantz, Lars Glimelius, Albin Fredriksson

Summary: Discrete proton arcs can be implemented with reasonable treatment times using a partitioning approach, making the proton arc treatments more robust to changes in patient anatomy.

MEDICAL PHYSICS (2023)

Article Radiology, Nuclear Medicine & Medical Imaging

Technical note: Evaluation of deep learning based synthetic CTs clinical readiness for dose and NTCP driven head and neck adaptive proton therapy

Rutger J. C. de Koster, Adrian Thummerer, Daniel Scandurra, Johannes A. Langendijk, Stefan Both

Summary: This study compared the dosimetric accuracy of daily CBCT-based sCT images to planning CTs and weekly rCTs in head and neck cancer patients. The results showed high similarity in target doses, but larger dose differences were observed in organs-at-risk.

MEDICAL PHYSICS (2023)

Article Oncology

Assessment of residual geometrical errors of clinical target volumes and their impact on dose accumulation for head and neck radiotherapy

Kelvin Ng Wei Siang, Stefan Both, Edwin Oldehinkel, Johannes A. Langendijk, Dirk Wagenaar

Summary: The study assesses the impact of residual geometrical errors on clinical target volumes dose coverage in head and neck cancer proton therapy. The results indicate that the difference in residual geometrical errors between propagated CTV and physician corrected CTV is minor, but variations in different regions are significant.

RADIOTHERAPY AND ONCOLOGY (2023)

Article Oncology

Proton arc therapy increases the benefit of proton therapy for oropharyngeal cancer patients in the model based clinic

Bas A. Jong, Erik W. Korevaar, Anneke Maring, Chimene I. Werkman, Daniel Scandurra, Guillaume Janssens, Stefan Both, Johannes A. Langendijk

Summary: This study investigated the potential impact of proton arc therapy (PAT) on oropharyngeal cancer (OPC) patients. PAT plans demonstrated better target coverage and reduced normal tissue complication probabilities (NTCPs) compared to IMPT and VMAT plans, leading to a significantly increased percentage of OPC patients qualifying for proton therapy.

RADIOTHERAPY AND ONCOLOGY (2023)

Article Oncology

The course of health-related quality of life in the first 2 years after a diagnosis of head and neck cancer: the role of personal, clinical, psychological, physical, social, lifestyle, disease-related, and biological factors

Irma M. Verdonck-de Leeuw, Laura H. A. Korsten, Annette van Nieuwenhuizen, Rob Baatenburg J. de Jong, Ruud H. Brakenhoff, Laurien M. Buffart, Femke Lamers, Johannes A. Langendijk, C. Rene Leemans, Jan H. Smit, Mirjam A. Sprangers, Robert P. Takes, Chris H. J. Terhaard, Birgit I. Lissenberg-Witte, Femke Jansen

Summary: The purpose of this study was to investigate the relationship between the course of health-related quality of life (HRQOL) in the first 2 years after diagnosis and treatment of head and neck cancer (HNC) and various factors. The study found that baseline depressive symptoms, social contacts, and oral pain were significantly associated with the course of HRQOL. Factors like tumor subsite, social eating, stress, coughing, feeling ill, and IL-10 were also associated with the course of HRQOL. Post-treatment factors such as social contacts and weight loss were found to be significantly associated with the course of HRQOL from 6 to 24 months.

SUPPORTIVE CARE IN CANCER (2023)

Article Oncology

External validation of a lung cancer-based prediction model for two-year mortality in esophageal cancer patient cohorts

M. Berbee, C. T. Muijs, F. E. M. Voncken, L. Wee, M. Sosef, B. van Etten, J. W. van Sandick, F. A. R. M. Warmerdam, J. J. de Haan, E. Oldehinkel, J. M. van Dieren, L. Boersma, J. A. Langendijk, A. van der Schaaf, J. B. Reitsma, E. Schuit

Summary: This study externally validated a model for predicting 2-year total mortality in lung cancer patients in esophageal cancer patients. The intercept and/or slope of the original model needed adjustment to achieve good performance in esophageal cancer patients.

RADIOTHERAPY AND ONCOLOGY (2024)

Article Oncology

Season of radiotherapy and outcomes of head & neck cancer patients in the MACH-NC & MARCH meta-analyses

Elaine Limkin, Pierre Blanchard, Benjamin Lacas, Jean Bourhis, Mahesh Parmar, Lisa Licitra, Quynh-Thu Le, Sue S. Yom, Catherine Fortpied, Johannes Langendijk, Jan B. Vermorken, Jacques Bernier, Jens Overgaard, Jonathan Harris, Jean-Pierre Pignon, Anne Auperin

Summary: This study investigated the impact of season of radiotherapy on the outcomes of head and neck squamous cell cancer patients. The results showed that the season of radiotherapy did not have any significant effect on patient outcomes.

RADIOTHERAPY AND ONCOLOGY (2024)

Article Oncology

Low contralateral failure rate with unilateral proton beam radiotherapy for oropharyngeal squamous cell carcinoma: A multi-institutional prospective study from the proton collaborative group

Derek A. Mumaw, Allison J. Hazy, Aleksander Vayntraub, Thomas J. Quinn, Kamran Salari, John H. Chang, Noah Kalman, Sanford Katz, James Urbanic, Robert H. Press, Arpi Thukral, Henry Tsai, George E. Laramore, Jason Molitoris, Carlos Vargas, Samir H. Patel, Craig Stevens, Rohan L. Deraniyagala

Summary: This study evaluated contralateral recurrences in patients with oropharyngeal squamous cell carcinoma who received unilateral proton beam therapy. The results showed a favorable contralateral neck failure rate that was comparable to photon irradiation.

RADIOTHERAPY AND ONCOLOGY (2024)

Article Oncology

Outcomes following hypofractionated radiation therapy alone for surgically unfit early esophageal squamous cell carcinoma patients; a retrospective single center analysis

Kangpyo Kim, Dongryul Oh, Jae Myoung Noh, Yang Won Min, Hong Kwan Kim, Yong Chan Ahn

Summary: This study suggests that hypofractionated radiation therapy alone is a feasible option for early stage esophageal squamous cell carcinoma patients. Particularly, in patients with tumor length < 3 cm, this treatment scheme shows favorable local control rates with low incidence of esophageal toxicities.

RADIOTHERAPY AND ONCOLOGY (2024)

Article Oncology

Evaluation and analysis of risk factors of hearing impairment for nasopharyngeal carcinoma treated using intensity-modulated radiotherapy

Lin Chen, Jing Li, Kunpeng Li, Jiang Hu, Qingjie Li, Chenglong Huang, Gaoyuan Wang, Na Liu, Linglong Tang

Summary: This study analyzed the probability of hearing impairment after radiotherapy for nasopharyngeal carcinoma and developed a predictive model, providing dose limitation suggestions to improve patients' quality of life.

RADIOTHERAPY AND ONCOLOGY (2024)

Article Oncology

FLASH radiotherapy using high-energy X-rays: Current status of PARTER platform in FLASH research

Yiwei Yang, Jianxin Wang, Feng Gao, Zhen Liu, Tangzhi Dai, Haowen Zhang, Hongyu Zhu, Tingting Wang, Dexin Xiao, Kui Zhou, Zheng Zhou, Dai Wu, Xiaobo Du, Sen Bai

Summary: This paper provides a comprehensive description of the current status of PARTER, which is the first experimental FLASH platform utilizing megavoltage X-rays. It showcases the reliable performance and stability of the dosimeters and monitors used in PARTER, as well as the satisfactory dose distribution and characteristics of the FLASH X-rays. The platform effectively meets the requirements of preclinical research on megavoltage X-ray FLASH and undergoes continuous upgrades.

RADIOTHERAPY AND ONCOLOGY (2024)

Article Oncology

Exploring published and novel pre-treatment CT and PET radiomics to stratify risk of progression among early-stage non-small cell lung cancer patients treated with stereotactic radiation

Maria Thor, Kelly Fitzgerald, Aditya Apte, Jung Hun Oh, Aditi Iyer, Otasowie Odiase, Saad Nadeem, Ellen D. Yorke, Jamie Chaft, Abraham J. Wu, Michael Offin, Charles B. Simone Ii, Isabel Preeshagul, Daphna Y. Gelblum, Daniel Gomez, Joseph O. Deasy, Andreas Rimner

Summary: The purpose of this study was to identify predictors of disease progression in early-stage non-small cell lung cancer (NSCLC) patients after receiving definitive stereotactic body radiation therapy (SBRT). The results showed that tumor diameter and SUVmax were the most frequently reported features associated with progression/survival, and a re-fitted model including these two features had the best performance.

RADIOTHERAPY AND ONCOLOGY (2024)

Article Oncology

A comprehensive predictive model for radiation-induced brain injury in risk stratification and personalized radiotherapy of nasopharyngeal carcinoma

Yong-Qiao He, Tong-Min Wang, Da-Wei Yang, Wen-Qiong Xue, Chang-Mi Deng, Dan-Hua Li, Wen-Li Zhang, Ying Liao, Ruo-Wen Xiao, Lu-Ting Luo, Hua Diao, Xia-Ting Tong, Yan-Xia Wu, Xue-Yin Chen, Jiang-Bo Zhang, Ting Zhou, Xi-Zhao Li, Pei-Fen Zhang, Xiao-Hui Zheng, Shao-Dan Zhang, Ye-Zhu Hu, Guan-Qun Zhou, Jun Ma, Ying Sun, Wei-Hua Jia

Summary: In this study, researchers aimed to establish a predictive model for radiation-induced brain injury (RBI) in nasopharyngeal carcinoma (NPC) patients by incorporating clinical factors and newly developed genetic variants. They conducted a large-scale retrospective study and a genome-wide association study to develop a polygenic risk score (PRS) for RBI risk prediction. The results showed that the PRS, combined with clinical factors, improved the accuracy of RBI risk stratification and suggested personalized radiotherapy.

RADIOTHERAPY AND ONCOLOGY (2024)

Review Oncology

Brachytherapy is an effective and safe salvage option for re-irradiation in recurrent glioblastoma (rGBM): A systematic review

Xiaoyong Xiang, Zhe Ji, Jing Jin

Summary: A review of studies suggests that brachytherapy as a salvage therapy for recurrent glioblastoma shows acceptable safety and good post-treatment clinical efficacy for selected patients.

RADIOTHERAPY AND ONCOLOGY (2024)

Article Oncology

External validation of a lung cancer-based prediction model for two-year mortality in esophageal cancer patient cohorts

M. Berbee, C. T. Muijs, F. E. M. Voncken, L. Wee, M. Sosef, B. van Etten, J. W. van Sandick, F. A. R. M. Warmerdam, J. J. de Haan, E. Oldehinkel, J. M. van Dieren, L. Boersma, J. A. Langendijk, A. van der Schaaf, J. B. Reitsma, E. Schuit

Summary: This study externally validated a model for predicting 2-year total mortality in lung cancer patients in esophageal cancer patients. The intercept and/or slope of the original model needed adjustment to achieve good performance in esophageal cancer patients.

RADIOTHERAPY AND ONCOLOGY (2024)

Article Oncology

Nine years of plan of the day for cervical cancer: Plan library remains effective compared to fully online-adaptive techniques

Dominique Reijtenbagh, Jeremy Godart, Joan Penninkhof, Sandra Quint, Andras Zolnay, Jan-Willem Mens, Mischa Hoogeman

Summary: This study compared the performance of the current PotD strategy with non-adaptive and fully online-adaptive techniques in the treatment of cervical cancer patients. The findings show that the PotD protocol is effective in improving normal tissue sparing compared to no adaptation, while fully online-adaptive approaches can further reduce target volume but come with a more complex workflow.

RADIOTHERAPY AND ONCOLOGY (2024)

Article Oncology

Prediction of radiation pneumonitis using the effective α/β of lungs and heart in NSCLC patients treated with proton beam therapy

Albrecht Weiss, Steffen Loeck, Ting Xu, Zhongxing Liao, Aswin L. Hoffmann, Esther G. C. Troost

Summary: Traditional models for predicting radiation pneumonitis may not be applicable to non-small cell lung cancer patients treated with passively-scattered proton therapy. The use of effective alpha/beta parameter can predict the occurrence of radiation pneumonitis in these patients.

RADIOTHERAPY AND ONCOLOGY (2024)

Article Oncology

Primer shot fractionation with an early treatment break is theoretically superior to consecutive weekday fractionation schemes for early-stage non-small cell lung cancer

Z. A. R. Gouw, J. Jeong, A. Rimner, N. Y. Lee, A. Jackson, A. Fu, J-j. Sonke, J. O. Deasy

Summary: This study investigates the effectiveness of non-uniform fractionation schedules in radiotherapy for early-stage non-small cell lung cancer. Through modeling, optimized schedules are proposed to minimize local failures and toxicity risk. The results suggest that non-standard primer shot fractionation can reduce hypoxia-induced radioresistance and improve treatment outcomes.

RADIOTHERAPY AND ONCOLOGY (2024)

Article Oncology

Curative carbon ion radiotherapy in a head and neck mucosal melanoma series: Facing the future within multidisciplinarity

Sara Ronchi, Alessandro Cicchetti, Maria Bonora, Rossana Ingargiola, Anna Maria Camarda, Stefania Russo, Sara Imparato, Paolo Castelnuovo, Ernesto Pasquini, Piero Nicolai, Mohssen Ansarin, Michele Del Vecchio, Marco Benazzo, Ester Orlandi, Barbara Vischioni

Summary: This study evaluates the efficacy and toxicity of carbon ion radiotherapy (CIRT) in locally advanced head and neck mucosal melanoma patients. The results show that CIRT is safe and effective in treating the local region, and immunotherapy after relapse can improve overall survival. However, further prospective trials are needed to assess the role of targeted/immune- systemic therapy in this disease.

RADIOTHERAPY AND ONCOLOGY (2024)

Article Oncology

The rise of negative portrayals of radiation oncology: A textual analysis of media news

Dominik Wawrzuta, Justyna Klejdysz, Marzanna Chojnacka

Summary: This study analyzed articles about radiation oncology published in The New York Times since its inception in 1851, and identified changes in media sentiment and prevalent themes related to radiotherapy. The findings suggest an increasing negative sentiment in media coverage towards radiotherapy, with a shift towards reporting treatment errors, toxicity, and ineffectiveness.

RADIOTHERAPY AND ONCOLOGY (2024)

Article Oncology

Season of radiotherapy and outcomes of head & neck cancer patients in the MACH-NC & MARCH meta-analyses

Elaine Limkin, Pierre Blanchard, Benjamin Lacas, Jean Bourhis, Mahesh Parmar, Lisa Licitra, Quynh-Thu Le, Sue S. Yom, Catherine Fortpied, Johannes Langendijk, Jan B. Vermorken, Jacques Bernier, Jens Overgaard, Jonathan Harris, Jean-Pierre Pignon, Anne Auperin

Summary: This study investigated the impact of season of radiotherapy on the outcomes of head and neck squamous cell cancer patients. The results showed that the season of radiotherapy did not have any significant effect on patient outcomes.

RADIOTHERAPY AND ONCOLOGY (2024)

Article Oncology

Meta-analysis of 5-day preoperative radiotherapy for soft tissue sarcoma (5D-PREORTS)

Fabio L. Cury, Gustavo A. Viani, Andre G. Gouveia, Camila V. S. Freire, Gabriel de A. Grisi, Fabio Y. Moraes

Summary: In limb-sparing treatment of soft tissue sarcoma patients, a 5-day course of preoperative radiotherapy results in high local control and favorable R0 margins, with acceptable complication rates, particularly for patients receiving higher biological equivalent doses.

RADIOTHERAPY AND ONCOLOGY (2024)